Role of Botulinum Toxin Type-A (BTX-A)‎ in the Management of Trigeminal Neuralgia

المؤلف

Verma, Gaurav

المصدر

Pain Research and Treatment

العدد

المجلد 2013، العدد 2013 (31 ديسمبر/كانون الأول 2013)، ص ص. 1-6، 6ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2013-10-01

دولة النشر

مصر

عدد الصفحات

6

التخصصات الرئيسية

الأمراض
الطب البشري

الملخص EN

Trigeminal neuralgia (TN) is a clinical condition characterized by paroxysmal attacks of severe and electric shock-like pain along the distribution of one or more branches of the trigeminal nerve.

Various medicinal or surgical modalities have been employed in the past with variable success.

Newer methods were tried in search of permanent cure or long-lasting pain relief.

The purpose of this paper is to present the review of the literature regarding the use of botulinum toxin type-A (BTX-A) in the management of trigeminal neuralgia.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Verma, Gaurav. 2013. Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia. Pain Research and Treatment،Vol. 2013, no. 2013, pp.1-6.
https://search.emarefa.net/detail/BIM-501631

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Verma, Gaurav. Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia. Pain Research and Treatment No. 2013 (2013), pp.1-6.
https://search.emarefa.net/detail/BIM-501631

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Verma, Gaurav. Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia. Pain Research and Treatment. 2013. Vol. 2013, no. 2013, pp.1-6.
https://search.emarefa.net/detail/BIM-501631

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-501631